Saw Palmetto "Moderate" Quality Evidence Shows BPH Symptom Relief - USP
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Pharmacopeia's final monograph on saw palmetto lists 10 published studies on the ingredient that met the USP quality standard of Level II or higher, under the organization's new criteria for evidence submission for botanicals.
You may also be interested in...
USP Ephedra Review Scheduled For July; RAND Report Slated For Early Fall
The U.S. Pharmacopeia will discuss standard-setting issues related to the supplement ingredient ephedra during an internal meeting July 17
USP Ephedra Review Scheduled For July; RAND Report Slated For Early Fall
The U.S. Pharmacopeia will discuss standard-setting issues related to the supplement ingredient ephedra during an internal meeting July 17
USP Ephedra Review Scheduled For July; RAND Report Slated For Early Fall
The U.S. Pharmacopeia will discuss standard-setting issues related to the supplement ingredient ephedra during an internal meeting July 17